News

Dolphin Medical Services Limited informed the BSE Limited that the trading window for securities of the company for designated persons and insiders will be closed from Thursday, October 01, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the second quarter ended September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Dolphin Medical Services Limited informed the Bombay Stock Exchange that its board of directors approved the appointment of Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director, and the change of Mr. Rajesh Kumar Mallour (DIN: 08125774) from Professional to Promoter Director, during a meeting held on September 21, 2026. The board also approved the reconstitution of various committees and authorized Mr. Rajesh Kumar Mallour to make necessary filings with stock exchanges and regulatory authorities regarding a proposed reclassification of Promoter/Promoter Group.

Dolphin Medical Services Limited informed the Bombay Stock Exchange that its board of directors approved the appointment of Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director, and the change of Mr. Rajesh Kumar Mallour (DIN: 08125774) from Professional to Promoter Director, during a meeting held on September 21, 2026. The board also approved the reconstitution of various committees and authorized Mr. Rajesh Kumar Mallour to make necessary filings with stock exchanges and regulatory authorities regarding a proposed reclassification of Promoter/Promoter Group.

Dolphin Medical Services will hold a meeting of the Board of Directors of the Company on 14 August 2026.

Net profit of Dolphin Medical Services reported to Rs 0.01 crore in the quarter ended March 2026 as against net loss of Rs 0.07 crore during the previous quarter ended March 2025. Sales rose 35.71% to Rs 0.19 crore in the quarter ended March 2026 as against Rs 0.14 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.04 crore in the year ended March 2026 as against net loss of Rs 0.03 crore during the previous year ended March 2025. Sales declined 3.85% to Rs 0.75 crore in the year ended March 2026 as against Rs 0.78 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.190.14 36 0.750.78 -4 OPM %10.53-35.71 -16.000 - PBDT0.03-0.04 LP 0.150.03 400 PBT0.01-0.07 LP 0.06-0.03 LP NP0.01-0.07 LP 0.04-0.03 LP Powered by Capital Market - Live News